Investing.com — Markets may be ignoring an important lesson of 2019, according to Goldman Sachs. The Wall Street bank said in a note
MILAN (Reuters) -Italian billionaire Francesco Gaetano Caltagirone has emerged as a leading player in the reshaping of Italy’s financial sector that is
By Valentina Za, Gianluca Semeraro and Mathieu Rosemain MILAN (Reuters) -Monte dei Paschi (MPS) CEO Luigi Lovaglio has pulled several all-nighters since arriving
SINGAPORE (Reuters) -Nasdaq futures slumped and technology shares slid in Japan on Monday as surging popularity of a Chinese discount artificial intelligence
Investing.com — A group of Indian digital news publishers, including those owned by billionaires Gautam Adani and Mukesh Ambani, have initiated a
Investing.com — Shares of BASF (BU:BASF) traded lower on Monday as the company’s preliminary 2024 figures posted a sharp decline in earnings
(Reuters) – Futures linked to the tech-heavy Nasdaq tumbled on Monday as the overwhelming popularity of an inexpensive Chinese artificial intelligence model
Investing.com – Shares in European chipmaking and data center-exposed stocks tumbled on Monday as investors fretted over the implications of the release of
(Reuters) – Property developer China Vanke said on Monday its chairman Yu Liang and CEO Zhu Jiusheng had resigned, amid growing concerns
By Rocky Swift TOKYO (Reuters) -Japan’s Fuji Media said on Monday its chairman and the head of its TV unit would step down
By Giulia Segreti and Valentina Za ROME/MILAN (Reuters) – Shares in Monte dei Paschi (MPS) fell again on Monday, extending Friday’s losses, signalling
Investing.com — Shares of British Land (LSE:LON:BLND) fell 1.5% after the company announced the sale of a 50% stake in
Investing.com — Universal Music Group (AS:UMG) and Spotify (NYSE:SPOT) have announced a new multi-year deal for recorded music and publishing, the companies
House Majority Leader Steve Scalise, R-La., is hammering Democrats over the partial government shutdown as its effects begin to hit millions of
The Food and Drug Administration (FDA) rolled out a new platform, backed by artificial intelligence, that will streamline publicly accessible reporting
In a sharp break from his long-standing defense of the Senate filibuster, Sen. John Cornyn, R-Texas, urged Republicans Wednesday to enact ‘whatever
